GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » Net Issuance of Debt

Shanghai Serum Bio Technology Co (SHSE:688163) Net Issuance of Debt : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Serum Bio Technology Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Shanghai Serum Bio Technology Co's net issuance of debt for the three months ended in Mar. 2024 was ¥0.0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.

Shanghai Serum Bio Technology Co Net Issuance of Debt Historical Data

The historical data trend for Shanghai Serum Bio Technology Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Serum Bio Technology Co Net Issuance of Debt Chart

Shanghai Serum Bio Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shanghai Serum Bio Technology Co Quarterly Data
Dec16 Dec17 Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Serum Bio Technology Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Serum Bio Technology Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Shanghai Serum Bio Technology Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Serum Bio Technology Co (SHSE:688163) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » Net Issuance of Debt
Comparable Companies
SZSE:000004 SHSE:688217 SZSE:300871 BJSE:839729 BJSE:837344 SHSE:688189 SZSE:002872 SZSE:002566 SZSE:002873 SZSE:002286 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 1288, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Website
http://www.serum-china.com.cn
Shanghai Serum Bio Technology Co Ltd is engaged in the research, development, production and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety.

Shanghai Serum Bio Technology Co (SHSE:688163) Headlines

No Headlines